Global Floor Standing Kiosk Market
As the global economy mends, the 2021 growth of Floor Standing Kiosk will have significant change ... Read More
As the global economy mends, the 2021 growth of Gastroesophageal Reflux Disease Device will have significant change from previous year. According to our (LP Information) latest study, the global Gastroesophageal Reflux Disease Device market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Gastroesophageal Reflux Disease Device market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Gastroesophageal Reflux Disease Device market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Gastroesophageal Reflux Disease Device market, reaching US$ million by the year 2028. As for the Europe Gastroesophageal Reflux Disease Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Gastroesophageal Reflux Disease Device players cover Addex Therapeutics, Aros Pharma, AstraZeneca, and Eisai, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastroesophageal Reflux Disease Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Esophagoscopy and Gastroscopy
Fundoplication Devices
Manometry System
PH Monitoring System
Radio Frequency Ablation Devices
Sphincter Augmentation Devices
Ultrasonic Surgical Endostaplers
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital-Based Outpatient Departments (HOPD)
Ambulatory Surgical Centers
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Addex Therapeutics
Aros Pharma
AstraZeneca
Eisai
EndoGastric Solutions
KARL STORZ
Medigus
Olympus
PENTAX Medical
Pfizer
Procter & Gamble
Takeda Pharmaceutical
As the global economy mends, the 2021 growth of Floor Standing Kiosk will have significant change ... Read More
As the global economy mends, the 2021 growth of Self-Service Interactive Kiosk will have signific ... Read More
As the global economy mends, the 2021 growth of Interactive Kiosk Solutions will have significant ... Read More
As the global economy mends, the 2021 growth of Dry Type Cast Resin Transformers will have signif ... Read More